21 results
Fantastic handout on anticoagulation by Dr. Jessie Donato, superstar medical educator and hospitalist at ⁦@ClevelandClinic⁩ ⁦@CCF_IMCHIEFS⁩

#Anticoagulation
Fantastic handout on anticoagulation ... CCF_IMCHIEFS⁩ #Anticoagulation ... HeparinDrip #gtt #Algorithm ... PTT #Monitoring #Management ... #Goals #Pharmacology
Approach to Antithrombotic Therapy in Peripheral Artery Disease
Increased Ischemic Risk:
 • Prior MI
 • Diabetes
 •
Bleeding Risk: • Anticoagulation ... bypass • Below-knee ... Antithrombotic #management ... #antiplatelet #algorithm
Choice of anticoagulant for treatment of pulmonary embolism
 • Malignancy - LMWH
 • To avoid parenteral
for treatment of pulmonary ... clearance <30 mL ... decisionaid #vte #anticoagulation ... #pharmacology
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Framework and Management ... Definition: 150-600 mL ... Primary Vascular: Pulmonary ... Coagulopathy 4) Reverse Anticoagulation ... #pulmonary #criticalcare
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... #prescribing #Pulmonary ... #Algorithm #treatment ... #pharmacology
Atrial Fibrillation Overview

Symptoms:
Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

1. Why?
Cardiac:
• Valvular heart disease
•
Noncardiac: • Pulmonary ... Anticoagulation ... Fibrillation #Cardiology #Management ... #Algorithm
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Dobutamine 2-20 mcg ... Epinephrine 0-20 mcg ... Properties #Table #Pharmacology ... #Effect #Management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation ... #management #algorithm ... #pharmacology #
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... >10% (or >200 mL ... systemicsclerosis #SSc #pulmonary ... #indications #management ... #treatment #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... thrombosis; PE = pulmonary ... Malignancy #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology